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ABSTRACT  
Objective: A new series 2-phenyl-3-(substituted benzo[d] thiazol-2-ylamino)-quinazoline-4(3H)-one was prepared by the fusion method by 
reacting 2-phenyl benzoxazine with 2-hydrazino benzothiazole and it was evaluated for their antimicrobial activity against gram positive, gram 
negative bacteria and fungi.  
Methods: Titled compounds were synthesized by fusion reactions. These compounds were evaluated by in vitro antibacterial and antifungal activity 
using the minimum inhibitory concentration and zone of inhibition methods. The synthesized compounds were characterized with the help of 
infrared, NMR and mass spectral studies. The benzothiazole moiety and the quinazoline ring have previously shown DNA gyrase inhibition and 
target related antibacterial activity. Thus, molecular docking studies of synthesized compounds were carried out (PDB: 3G75) to study the possible 
interaction of compounds with the target. The batch grid docking was performed to determine the probable.  
Results: These compounds showed significant activity against gram positive and gram negative bacteria as well against the fungi. The compound A5 
was found to be active against B. subtilis, P aeruginosa and C. albican at 12.5 µg/ml MIC. The compound A3 was found to be active against all 
microbial strains selected at 25 and 12.5 µg/ml MIC. 
Conclusion: Though the relationship between the activities shown by these compounds in, the antimicrobial study is still to be established, the 
docking studies conducted found to be consistent with antimicrobial results. Thus the results indicate that the designed structure can be a potential 
lead as an antimicrobial agent. 
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INTRODUCTION 
There has been a continual encounter between human and the 
multitude of microorganism that cause infection and disease. 
Recently it has been evidenced that there is an insistent increase in 
antibiotic resistance to many common bacterial pathogens such as 
Staphylococcus aureus. The number of cases of multidrug-resistant 
bacterial infections is increasing day by day. This situation requires 
the design of novel antimicrobial agents acting on novel targets.  
Benzothiazole derivatives show numerous biological activities such as 
antimicrobial [1], anticancer [2], antileishmanial [3], anti-diabetic and 
antifungal [4] activities. In recent years’ heterocyclic compounds and 
derivatives have attracted strong interest due to their biological and 
pharmacological properties. Substituted quinazoline-4-one have been 
shown to possess antibacterial, antifungal and antimicrobial activity 
[5-7]. Thus, it is revealed from the literature that benzothiazole, as well 
as quinazolin-4-one derivatives, hold diverse pharmacological activity. 
DNA gyrase is a bacterial enzyme that catalyzes the introduction of 
negative supercoils in a closed-circular DNA using the energy of the 
ATP hydrolysis. Since it was found only in prokaryotes and is vital 
for their survival; it has become an attractive target for antibacterial 
agents [8]. Benzothiazole and quinazoline derivatives were known 
to possess DNA gyrase inhibitory activity [9]. Thus, we thought to 
incorporate both leads together with the hope to have better 
antimicrobial potential. 
Thus, this paper reports the synthesis and antimicrobial activity of 
2-phenyl-3-(substituted benzo [d] thiazol-2-ylamino)-2-phenyl-
quinazolin-4(3H)-one. The molecular docking studies were also 
carried out to check the possible interactions of compounds with 
DNA gyrase active pocket. 
MATERIALS AND METHODS 
All the reagents and chemicals used were of analytical grade. The 
progress of the reaction and purity of all the synthesized compounds 
was monitored by TLC. IR spectra were recorded on Shimadzu FTIR 
8400S by using KBr, and the NMR spectra were recorded in NMR 
Varian-Mercury 300 MHz spectrometer in CDCl3 and values are 
expressed in ppm. 
Antimicrobial activity 
Zone of inhibition 
The compounds were evaluated for the antibacterial activity by the 
cup, plate method against gram-positive bacteria S. aureus (ATCC 
9144) B. subtilis (ATCC 6633) and gram-negative bacteria E. coli (ATCC 
25922), P. aeruginosa (ATCC 9027) and A. Niger (ATCC 16404) and C. 
albicans (ATCC 10231), at the concentration: 50 μg/ml, 100 μg/ml, 
150 μg/ml. The bacterial strains were obtained from NCL, and fungal 
strains were obtained from the microbiology department of Waghire 
College, Saswad. The ciprofloxacin 150 μg/ml and 150 μg/ml of 
fluconazole were used as reference drugs for antibacterial and 
antifungal study respectively. The bacteria were sub-cultured in the 
nutrient agar medium containing peptone (1%), beef extract (0.5%), 
sodium chloride (0.8%) and agar (2.5%), in distilled water. The 
solution was sterilized for 20 min at 15 psi pressure in an autoclave at 
120 °C. The basal medium 15-20 ml was poured into the sterile Petri 
dishes. After the solidification of the medium, the suspension of the 
organism was spread by the spreader and holes of 6 mm diameter 
were bored to form cups with the help of a sterile cork borer. In this 
cup 20 μl of 50 μg/ml, 100 μg/ml, 150 μg/ml (solvent DMSO) of the 
test compounds were added by the micropipette. The zone of 
inhibition was measured in mm after incubation at 37 °C for 48 h. 
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Minimum inhibitory concentration 
The microdilution susceptibility test was used for the determination 
of antibacterial and antifungal activity. The nutrient broth was 
prepared and added in microiter plates except first well in which 
inoculum was not added and considered as negative control. A stock 
solution of test compounds was prepared in DMSO (200 μg/ml) 
followed by twofold dilution at concentrations of (100, 50, 
25….3.125 μg/ml). The 75 µl inoculums were added to the other all 
wells containing test compounds ranging from 100, 50, 25….3.125 
μg/ml. The microtitre plates were then incubated at 37 °C for 48 h, 
and minimal inhibitory concentration was measured in the growth 
in the form of turbidity. The ciprofloxacin was used as reference 
drugs for the antibacterial study while fluconazole was used for 
antifungal study [10]. 
Docking studies  
The docking process was carried out to analyze the possible 
interactions between newly synthesized compounds and the 
selected cavity of the DNA gyrase enzyme. The high-resolution (2.30 
A °) X-ray structure of DNA gyrase complexed with pyrazolthiazole 
(PDB code 3G75) was imported into Vlife 3.5 MDS, and the ligand 
was extracted to leave a cavity. The protein was a dimer which was 
converted into monomer by deleting one-chain. Water molecules 
were removed from the monomer. The hydrogens were added in the 
protein molecule, and energy was minimized using Merck Molecular 
Force Field (MMFF). The structure of pyrazolthiazole extracted from 
the 3G75 protein was energy minimized using MMFF. The 
conformers of pyrazolthiazole, were generated and docked back into 
the corresponding binding pocket to determine the ability of the 
Biopredicta tool to reproduce the orientation and position of the 
inhibitor observed in the crystal structure. The docked 
conformations were further scored using dock score. Conformers of 
individual 3D optimized synthesized compounds A1 to A6 were 
generated using ‘systematic conformational search method’. In a 
systematic conformational search, a set of rotatable bonds is 
identified by the user and for each of these bonds; all possible 
conformers are examined as a function of each other. For each 
conformer generated by this set of rotations, all internal atomic 
distances were computed. A confirmation for which any distance 
less than the sum of the van der Waals radii of the interacting 
species was not considered. All the generated conformers with 
minimum and maximum torsion values were selected in the range 
of-180.00 to 180.00, and MMFF force field was selected for 
optimization of generated conformers. The optimized conformers 
were docked using the grid batch docking method. The interaction 
between synthesized compounds and DNA gyrase pocket was 
recorded.  
General procedure of synthesis 
Synthesis of 6-substituted-2-aminobenzothiazoles (B 1-6) 
To substituted aniline (0.078 mol) taken in a 250 ml round bottom 
flask, ammonium thiocyanate (0.156 mol) and 100 ml acetic acid 
was added. Bromine solution (0.02 mol) in acetic acid was added to 
the reaction mixture till an orange-yellow color appeared. The slurry 
was kept overnight (20 h), the precipitate was dissolved in water 
(200 ml), filtered to remove any undissolved matter and was 
basified with concentrated ammonia solution. The precipitate 
obtained was filtered, washed with water, dried and recrystallized 
using ethanol: water (80:20) mixture [11]. 
Synthesis of 6-substituted-2-hydrazino benzothiazole (BH 1-6) 
Concentrated hydrochloric acid (1 ml) was added dropwise with 
stirring to hydrazine hydrate (0.12 mol) at 5-6 °C followed by ethylene 
glycol (30 ml). Thereafter 2-amino substituted benzothiazole (20 
mmol) was added in portions, and the resultant mixture was 
irradiated in microwave at power level 7 for 1 h. The reaction progress 
was monitored by TLC using toluene: ethyl acetate (75:25) as mobile 
phase. The reaction mixture was cooled at room temperature and was 
washed with cold water to obtain the product. The resulting crude was 
recrystallized from ethanol to obtain the crystalline product [12]. 
Synthesis of 2-phenyl-4H-benzo[d] [1,3]-oxazin-4-one 
Anthranilic acid (0.01 mol) was dissolved in pyridine. Benzoyl 
Chloride (0.01 mol) was added to it and cooled. The reaction mixture 
was stirred at room temperature. A little quantity of the sample was 
taken and dissolved in water to check the formation of benzoxazine. 
As an anthranilic acid, benzoyl chloride and pyridine are water 
soluble, they get dissolved in water, but benzoxazine being insoluble, 
it forms a precipitate. When benzoxazine was formed, the entire 
reaction mixture was poured into a beaker containing 250 ml of 
water containing 10 % sodium bicarbonate. The benzoxazine so 
formed was filtered, dried and recrystallized from ethanol. A pale 
brown colored crystalline compound was obtained. Melting points 
were checked. The purity of the compounds was checked by TLC 
using benzene and petroleum ether solvent system in 7:3 ratio [13] 
General Procedure for Synthesis of 2-phenyl-3-(substituted 
benzo[d]thiazol-2-ylamino)-quinazolin-4(3H)-one (A1-6) 
0.1 mol of Substituted 2-hydrazino benzothiazole (BH1-6) was 
heated with 0.2 mol of substituted benzoxazin-4-one in a 50 ml 
beaker on a sand bath. The mixture was heated (controlled heating) 
with constant stirring until the product formed. Then the mixture 
was allowed to cool, and the product was suspended in water. The 
product obtained was recrystallized with ethanol. (80:20) 
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Fig. 1: Scheme of synthesis 
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Table 1: Data for 2-phenyl-3-(substituted benzo[d]thiazol-2-ylamino)-2-phenylquinazolin-4(3H)-one (A1-6) 
Compound R IR NMR (ppm) % 
yield 
A1 H 3124 (N-H), 3063 (Ar-CH)1619(C=N); 1712(C=O), 1265 (C-N), 
702(C-S) 
7.09-8.98 (m,13H, Ar-H); 11(s, 1H,-NH) 78 
A2 OCH3 3163 (N-H), 3047 (Ar-CH), 2985(CH),1604 (C=N) 1681(C=O), 1261 
(C-N), 1137(C-O-C), 812(C-S) 
7.1-8.9 (m, 12H, Ar-H), 12 (s, 1H, NH), 
3.24(s, 3H,-OCH3) 
70 
A3 Cl 3135 (N-H), 3070 (Ar-CH); 1681(C=N); 1766(C=O), 1257 (C-N), 
768(C-S) 
6.9-8.7(m, 12H, Ar-H), 11.3(s, 1H, NH) 60 
A4 CH3 3132 (N-H), 3089 (Ar-CH); 2924(CH) 1651(C=N) 1731(C=O), 1150 
(C-N), 783(C-S) 
2.39(s, 3H, CH3), 11.4 (s, 1H, NH), 7.29-
8.11(m, 12H) 
65 
A5 NO2 3194 (N-H), 3081 (Ar-CH); 1519(C=N); 1681(C=O), 1334 (C-N),  7.31-9.01(m, 12H), 11.9 (s, 1H, NH), 60 
A6 COCH3 3383 (N-H), 3063 (Ar--CH); 1689(C=N); 1712(C=O), 1265 (C-N) 7.38-8.52 (m, 12H), 11.9 (s, 1H, NH) 
2.59(s,3H, CH3), 
65 
 
RESULTS AND DISCUSSION 
The compounds B (1-6) were prepared as per reported method from 
para-substituted anilines by stirring with ammonium thiocyanate 
and bromine in acetic acid. The reaction mainly involves formation 
of intermediate phenylthiourea and cyclisation of which affords 6-
substituted 2-amino benzothiazole. The target compounds A(1-6) 
were synthesized by the route indicated in fig. 1. The compounds 
were prepared by heating substituted 2-hydrazino benzothiazoles 
(BH1-6) with 2 phenyl-benzo[d] [1,3] oxazin-4-one. The synthesized 
structures were confirmed by spectral analysis by 1H NMR, IR and 
were found consistent with the spectral data. IR spectra of A(1-6) 
revealed characteristic aromatic CH stretch between 3047-3120 cm-
1
. The C=N in benzothiazole is seen at 1519-1600 cm-1. The carbonyl 
(C=O) peak of quinazolinone is seen at 1731-1681 cm-1. The absence 
of NH-NH2 stretch at 3243-3317 cm-1 in the IR spectrum also 
confirms the formation of 2-phenyl-3-(substituted benzo[d]thiazol-
2-ylamino)-2-phenylquinazolin-4(3H)-ones. 
In the 1H NMR spectrum, a broad singlet at 9-12 ppm is seen for 
hydrazine protons. The aromatic protons were seen as multiplet 
signals at 6.89-9.05 ppm. The methoxy protons were seen downfield 
due to the presence of oxygen and seen as a singlet at 3.24 ppm and 
methyl protons as a singlet at 2.39 ppm.  
Antimicrobial activity  
The minimum inhibitory concentration of A (1-6) compounds was 
determined using a double dilution method. A zone of inhibition was 
determined using the cup plate method using ciprofloxacin and 
fluconazole as standard drugs for antibacterial and antifungal activity.
 
Table 2: Minimum inhibitory concentration (MIC) of 2-phenyl-3-(substituted benzo[d]thiazol-2-ylamino)-2-phenylquinazolin-4(3H)-one 
(A1-6) 
Compound S. aureus B. subtilis E. coli P. aeruginosa A. niger C. albicans 
A1 50 25 25 25 25 25 
A 2 50 25 50 25 25 25 
A 3 25 2525 251220 2512 25 25 
A 4 50 25 50 50 50 50 
A 5 50 12.512 251220 12.512 25 12.5 
A 6 50 50 50 50 50 50 
MIC given in µg/ml 
 
The compound A-5 with nitro substitution at the 6th position of 
benzothiazole was found to hold potential antibacterial and 
antifungal activity against B. subtilis, P. aeruginosa and C. albicans. 
(table 2) The compound A5 was found to be active against B. 
subtilis, P aeruginosa and C. albican at 12.5 µg/ml MIC.  
The compound A3 was found active against all microbes at 25 
µg/ml MIC. It was evident from the results of the zone of inhibition 
that compound A-5 and compound A-3 holds potential 
antibacterial activity. 
The zone of inhibition was determined using the cup plate method. 
Effect of standard drug, ciprofloxacin and synthesized compounds 
A1 to A-6 revealed that the synthesized compounds A1 to A6 are 
showed statistically significant antibacterial activity than standard 
ciprofloxacin, suggesting the compounds have similar antibacterial 
action but lesser than ciprofloxacin. 
Effect of standard drug, fluconazole and synthesized compounds A1 
to A-6 revealed that the synthesized compounds A1 to A6 are 
showed statistically significant antifungal activity than standard 
fluconazole, suggesting the compounds have similar antifungal 
action but lesser than fluconazole. From the results it can be said 
that the compound with nitro group substitution holds antibacterial 
and antifungal potential comparable to standard drugs. 
Docking  
To predict the probable interactions of newly synthesized 
compounds with the active site of DNA gyrase enzyme, docking 
studies were carried out using MDS V-life 3.5 software. The dock 
score, hydrophobic interactions, Van der Waal interactions and 
hydrogen bonds formed with surrounding amino acids were used 
to predict the binding modes, binding affinities and orientation of 
docked compounds in the active sites of DNA gyrase enzyme.  
The active site (cavity no 1) was defined to include residues within 
10.0 A ° radius of any of the interaction. The docking procedure 
was validated by docking the pyrazolthiazole extracted from PDB 
active pocket. The molecular docking results revealed a docking 
score of-4.8kcal/mol for pyrazolthiazole, and it forms a single 
hydrogen bond with Ser-55. The compound A-3 and A-5 which are 
the most active compound as antibacterial possess dock score of-
5.13,-5.27 kcal/mol respectively. 
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Fig. 2: Data expressed as mean±SEM. Data analyzed by two-way ANOVA followed by Dunnet test. All test groups are compared with the 
control group, Ciprofloxacin ***p<0.001 
 
 
Fig. 3: Data expressed as mean±SEM. Data analyzed by two-way ANOVA followed by Dunnet test. All test groups are compared with the 
control group, fluconazole ***p<0.001 
 
Table 3: Dock score and binding interactions of newly synthesized compounds A (1-6) 
Compound Dock score (kcal/mol) 
A1 -5.3 
A2 -5.11 
A3 -5.13 
A4 -5.25 
A5 -5.27 
A6 -5.00 
Reference -4.8 
 
CONCLUSION 
The number of substituted benzothiazoles fused with quinazoline 
moieties was synthesized and screened for antibacterial and 
antifungal activity. The antimicrobial activities for the synthesized 
compounds (A1-6) have been shown in table 2, fig. 2 and fig. 3 
Ciprofloxacin was used as a standard for antibacterial activity. 
Similarly, fluconazole was used for antifungal activity as standard. 
All the newly synthesized compounds showed moderate to good 
potency against different bacterial strains. Out of which compound 
A5 and A3 showed prominent antibacterial and antifungal activity. 
As some synthesized compounds show good activity which develops 
a productive environment for the development of a new class of 
antimicrobial agents. 
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